3 August 2009 - Delphic Diagnostics, a provider of specialist diagnostics for HIV and hepatitis, has appointed Alun Williams as chief executive.
His background includes pharmaceuticals, clinical trials and medical devices.
Delphic has just completed an GBP850K fund-raising exercise from existing investors MMC Ventures and The Capital Fund, to support its transition from a provider of diagnostic services in HIV and hepatitis into a company able to address the growing market for adaptive trials and personalised medicine across a range of therapy areas.
